J&J COVID-19 Vaccine Advisory

Tuesday, April 13, 2021

A ‘rare and severe’ type of blood clot has recently been seen in six people after the administration of Johnson & Johnson’s COVID-19 vaccine. The FDA and CDC have recommended pausing further administration of the vaccine pending further review. Due to this uncertainty, the Tisch MS Research Center of New York recommends that patients of the IMSMP avoid the J & J vaccine for now until further information becomes available.


News Archive


Tisch MS Research Center of New York

521 West 57th Street
4th Floor
New York, NY 10019
(646) 557-3900

Privacy Policy


Support Tisch MS

Support Tisch MS and our innovative research leading to treatments that improve the lives of patients.